A new cannabis chemovar index linked specific THC-terpene combinations to different patient outcomes
A novel indexing system classifying cannabis flower by cannabinoid and terpene combinations found that different chemovars were associated with distinct patient-reported outcomes for symptom relief and side effects.
Quick Facts
What This Study Found
The Vigil Index of Cannabis Chemovars created a scalable classification system combining major cannabinoid and terpene contents. The most commonly consumed chemovars showed different effectiveness profiles and side effect patterns across 204 users.
Key Numbers
204 users from 2016-2021 tracked via mobile app. Cannabis flower classified by cannabinoid and terpene content into chemovars. Different chemovars associated with distinct treatment effectiveness and side effect profiles.
How They Did This
Observational study using a mobile app. 204 people tracked cannabis flower consumption between 2016-2021. Cannabis products were classified by cannabinoid and terpene profiles into chemovars. Patient-reported outcomes compared across chemovar categories.
Why This Research Matters
The cannabis market treats products as interchangeable within broad categories (indica, sativa, hybrid). A chemistry-based classification system could help patients and clinicians identify which specific formulations work for their needs.
The Bigger Picture
Moving from strain names to chemical profiles represents a fundamental shift in how cannabis products are understood. If specific cannabinoid-terpene combinations consistently produce different effects, it could transform cannabis from a black box into precision medicine.
What This Study Doesn't Tell Us
Small, self-selected sample of app users. Non-randomized, observational design. Cannabis product testing may not be perfectly accurate. Patient-reported outcomes are subjective. Chemovar categories may oversimplify complex plant chemistry.
Questions This Raises
- ?Would larger validation studies confirm chemovar-outcome associations?
- ?Could this indexing system be adopted by dispensaries to improve product selection guidance?
Trust & Context
- Key Stat:
- 204 users tracked; different cannabinoid-terpene chemovars linked to distinct outcomes
- Evidence Grade:
- Novel observational framework with small sample. Proof-of-concept for a classification system that needs larger validation.
- Study Age:
- Published 2023. Data from 2016-2021.
- Original Title:
- Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars.
- Published In:
- Journal of cannabis research, 5(1), 4 (2023)
- Authors:
- Vigil, Jacob Miguel, Stith, Sarah See, Brockelman, Franco(2), Keeling, Keenan, Hall, Branden
- Database ID:
- RTHC-05002
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Does the type of cannabis strain matter for medical effects?
This study suggests yes. When cannabis flower was classified by actual chemical content (cannabinoid and terpene levels) rather than just strain name, different chemical profiles were associated with different symptom relief and side effects. This supports the idea that specific chemical combinations matter.
What is a cannabis chemovar?
A chemovar (chemical variety) classifies cannabis by its actual phytochemical composition, especially cannabinoid and terpene levels. Unlike strain names, which are inconsistent across growers, chemovars reflect what is actually in the plant. The Vigil Index creates a systematic way to categorize and compare these chemical profiles.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05002APA
Vigil, Jacob Miguel; Stith, Sarah See; Brockelman, Franco; Keeling, Keenan; Hall, Branden. (2023). Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars.. Journal of cannabis research, 5(1), 4. https://doi.org/10.1186/s42238-022-00170-9
MLA
Vigil, Jacob Miguel, et al. "Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis Chemovars.." Journal of cannabis research, 2023. https://doi.org/10.1186/s42238-022-00170-9
RethinkTHC
RethinkTHC Research Database. "Systematic combinations of major cannabinoid and terpene con..." RTHC-05002. Retrieved from https://rethinkthc.com/research/vigil-2023-systematic-combinations-of-major
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.